REGN
REGENERON PHARMACEUTICALS
Institutional Ownership ยท Q4 2025
Filing: Q4 2025REGENERON PHARMACEUTICALS (REGN) is held by 1,310 institutional investors with combined holdings of $59.9B. Major holders include VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP.
Institutional Holders
1,310
Total Value
$59.9B
Ownership %
75.3%